← Scroll for more →
Financial Statements — GYGY
Balance Sheet
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q1 2025 | Q4 2024 | Q4 2023 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 0.02 | -- | 0.09 | -- | 0.07 | 0.07 |
| Accounts Receivable | 0.00 | -- | 0.00 | -- | 0.00 | -- |
| Inventory | 1.14 | -- | 1.14 | -- | 1.20 | -- |
| Total Current Assets | 1.34 | -- | 1.23 | -- | 1.32 | -- |
| Property, Plant & Equipment | 0.02 | -- | 0.03 | -- | 0.05 | -- |
| Total Non-current Assets* | 0.02 | -- | 0.03 | -- | 0.05 | -- |
| Total Assets | 1.37 | -- | 1.27 | -- | 1.38 | -- |
| Accounts Payable | 0.70 | -- | 0.23 | -- | 0.26 | -- |
| Short-term Debt | 3.58 | -- | 3.29 | -- | 1.89 | -- |
| Total Current Liabilities | 1.52 | -- | 3.56 | -- | 2.37 | -- |
| Total Non-current Liabilities* | 3.00 | -- | 0.00 | -- | 0.00 | -- |
| Total Liabilities* | 4.52 | -- | 3.56 | -- | 2.37 | -- |
| Retained Earnings | (24.71) | -- | (20.68) | -- | (19.90) | -- |
| Total Stockholder Equity | (3.16) | (2.34) | (2.30) | (1.33) | (0.99) | 0.63 |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Total Revenue | 0.00 | -- | 0.02 | -- |
| Cost of Revenue | 0.00 | -- | 0.01 | -- |
| Gross Profit | 0.00 | -- | 0.00 | -- |
| Research & Development | 0.12 | -- | 0.13 | -- |
| Selling, General & Admin | 2.92 | -- | 0.12 | -- |
| Total Operating Expenses | 3.08 | -- | 0.27 | -- |
| Operating Income | (3.08) | -- | (0.27) | -- |
| Interest Expense | 0.01 | -- | -- | -- |
| Pretax Income | (3.33) | -- | 0.00 | -- |
| Net Income | (3.33) | (0.70) | 0.00 | (0.15) |
| Basic EPS | (0.22) | -- | 0.00 | -- |
| Diluted EPS | (0.22) | -- | 0.00 | -- |
← Scroll for more columns →
Cash Flow Statement
(in thousands USD)| Metric | Q2 2026 |
|---|---|
| Operating Cash Flow | (796.58) |
| Investing Cash Flow | 0.69 |
| Financing Cash Flow | 729.53 |
← Scroll for more columns →